| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10817855 | Clinical Biochemistry | 2015 | 4 Pages |
Abstract
Most dyslipidemia patients in Guangzhou remain untreated. POCT in China is feasible, and its widespread use might improve dyslipidemia awareness, treatment and control.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Pei-dong Zhang, Lin-yun He, Yang Guo, Peng Liu, Gong-xin Li, Li-zi Wang, Ying-feng Liu,